Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Endocrinology | Nephrology | Family Medicine
Search Medical Condition
Diabetic Kidney Disease Clinical Trials
A listing of Diabetic Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (59) clinical trials
Diabetic Kidney Disease
Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit
RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies
The purpose of this research bio-repository study is to collect demographic, clinical, biochemical, histological, and genetic (RNA) data and samples from a large population of subjects with a variety of renal disease states, including diabetic, inflammatory, autoimmune and transplant related renal conditions, in order to assess for factors that may ...
BAY-94-8862/16244 - A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
Demonstrate whether, in addition to standard of care finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occurrence of kidney failure , a sustained decrease of eGFR ≥ 40% from baseline over at least 4 weeks or ...
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type2diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care
Demonstrate whether finerenone QD is superior to placebo QD in delaying the time to first occurrence of cardiovascular mortality and morbidity in subjects with T2DM and the clinical diagnosis of DKD. Randomized at 1:1 ratio. Subjects will take one pill once a day.
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven PhaseIII study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease insubjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
Demonstrate whether finerenone is superior to placebo in delaying the progression of kidney disease. Randomized at 1:1 ratio. Subjects will take one pill once a day.
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care
The primary objective of this study is to: Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the time to first occurrence of cardiovascular (CV) mortality and morbidity in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease ...
A randomized, double placebo-controlled, parallel group, multi-center, event driven phase II study to investigate the efficacy and safety of Finerenone, in addition to standard care, on the progression of kidney disease in subjects with type II diabetes and the clinical diagnosis of diabetic kidney.
The primary objective of this study is to: Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occurrence of kidney failure, a sustained decrease of eGFR ≥ 40% ...
Type 2 Diabetes Mellitus with Moderate Renal Impairment
This study evaluates an investigational oral tablet compared to placebo that may help manage your blood glucose levels.
Type 2 Diabetes with Severe Chronic Kidney Disease with inadequate glycemic control.
This study is to evaluate the safety of an existing diabetes drug and how it may help individuals with kidney disease.
Diabetic Nephropathy Research Study
A research study is evaluating an investigational medication for kidney disease due to diabetes (diabetic nephropathy). This research study may be an option if you: • Are 18 years old or older • Are male or a postmenopausal woman, or a female without childbearing potential • Have impaired kidney function ...
